Search research articles
Contact Us
Filters
Showing results (171-180 of 820) with videos related to
Page
of 82
Sort By:
European Heart Journal
|
October 11, 2024
Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fraction
Massimo Volpe, Leonarda Galiuto
European Heart Journal
|
December 19, 2025
Weekly Journal Scan: GRACE 3.0 redefines cardiovascular risk assessment and individualized care in non-ST-elevation acute coronary syndromes through machine learning
Giovanna Liuzzo, Massimo Volpe
European Heart Journal
|
December 19, 2025
Weekly Journal Scan: Exploring the balance of benefits and harms of intensive blood pressure control
Daniela Pedicino, Massimo Volpe
Expert Review of Cardiovascular Therapy
|
August 4, 2011
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy
Giuliano Tocci, Massimo Volpe
Heart International
|
October 7, 2011
Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases
Speranza Rubattu, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
May 27, 2011
2010 position paper of the Italian Society of Hypertension (SIIA): angiotensin receptor blockers and risk of cancer
Massimo Volpe, Alberto Morganti,
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
September 8, 2011
Modern clinical management of arterial hypertension: fixed or free combination therapies?
Giuliano Tocci, Massimo Volpe
Cardiovascular Research
|
November 24, 2020
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
Massimo Volpe, Giovanna Gallo
European Heart Journal
|
November 16, 2020
The second life of the ambiguous angiotensin-converting enzyme 2 as a predictive biomarker for cardiometabolic diseases and death
Massimo Volpe, Carlo Patrono
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
September 2, 2022
Flu Vaccination as a Key Prevention Recommendation for Patients at High Cardiovascular Risk: The Next Season's Scenario
Allegra Battistoni, Massimo Volpe
Page
of 82
Search research articles
Search
Showing results (171-180 of 820) with videos related to
Sort By:
Page
of 82
European Heart Journal
|
October 11, 2024
Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fraction
Massimo Volpe, Leonarda Galiuto
European Heart Journal
|
December 19, 2025
Weekly Journal Scan: GRACE 3.0 redefines cardiovascular risk assessment and individualized care in non-ST-elevation acute coronary syndromes through machine learning
Giovanna Liuzzo, Massimo Volpe
European Heart Journal
|
December 19, 2025
Weekly Journal Scan: Exploring the balance of benefits and harms of intensive blood pressure control
Daniela Pedicino, Massimo Volpe
Expert Review of Cardiovascular Therapy
|
August 4, 2011
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy
Giuliano Tocci, Massimo Volpe
Heart International
|
October 7, 2011
Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases
Speranza Rubattu, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
May 27, 2011
2010 position paper of the Italian Society of Hypertension (SIIA): angiotensin receptor blockers and risk of cancer
Massimo Volpe, Alberto Morganti,
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
September 8, 2011
Modern clinical management of arterial hypertension: fixed or free combination therapies?
Giuliano Tocci, Massimo Volpe
Cardiovascular Research
|
November 24, 2020
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists
Massimo Volpe, Giovanna Gallo
European Heart Journal
|
November 16, 2020
The second life of the ambiguous angiotensin-converting enzyme 2 as a predictive biomarker for cardiometabolic diseases and death
Massimo Volpe, Carlo Patrono
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
September 2, 2022
Flu Vaccination as a Key Prevention Recommendation for Patients at High Cardiovascular Risk: The Next Season's Scenario
Allegra Battistoni, Massimo Volpe
Page
of 82